CFLT · As filed with the SEC

Confluent balance sheet, by fiscal year

The statement as Confluent presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Consolidated Balance Sheets · USD thousands

USD thousandsFY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
ASSETS
Current assets:
Cash and cash equivalents347,210385,980349,761435,7811,375,93236,789
Marketable securities1,706,7621,524,5831,551,0091,491,044640,085251,756
Accounts receivable, net390,752314,306229,962178,188137,491105,971
Deferred contract acquisition costs54,54547,27143,93735,88327,64614,403
Prepaid expenses and other current assets107,74479,17976,98657,22944,91918,775
Total current assets2,607,0132,351,3192,251,6552,198,1252,226,073427,694
Property and equipment, net93,17978,68054,01229,08914,4286,718
Operating lease right-of-use assets4,9368,81810,06129,47837,28148,273
Goodwill and intangible assets, net——55,490,000———
Goodwill164,406164,406————
Intangible assets, net6,0547,924————
Deferred contract acquisition costs, non-current77,73771,46875,81568,40151,17833,196
Other assets, non-current31,94512,29613,77619,75613,76910,238
Total assets2,985,2702,694,9112,460,8092,344,8492,342,729526,119
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable20,7087,5316,71421,4397,5911,646
Accrued expenses and other liabilities182,735194,250141,847102,75598,97433,711
Operating lease liabilities8,1788,6947,8907,3759,23610,492
Deferred revenue468,984378,771330,570290,185220,920142,901
Liability for early exercise of unvested stock options———2,576,00011,467,0005,049,000
Total current liabilities680,605589,246487,021424,330348,188193,799
Operating lease liabilities, non-current1,2059,13817,39125,13631,64540,440
Deferred revenue, non-current29,65530,43022,43632,64425,55716,292
Convertible senior notes, net1,095,9881,092,1491,088,3131,084,5001,080,7010
Other liabilities, non-current8,67812,72235,2338,7626,3577,203
Total liabilities1,816,1311,733,6851,650,3941,575,3721,492,448257,734
Redeemable convertible preferred stock, par value $0.00001 per share; 0 and 115,277,850 shares authorized as of December 30, 2021 and December 31, 2020, respectively; 0 and 115,277,850 shares issued and outstanding as of December 30, 2021 and December 31, 2020, respectively; aggregate liquidation preference of $0 and $575,085 as of December 30, 2021 and December 31, 2020, respectively————0574,634,000
Stockholders’ equity:
Preferred stock, par value of $0.00001 per share; 10,000 shares authorized as of December 31, 2025 and December 31, 2024; 0 shares issued and outstanding as of December 31, 2025 and December 31, 2024000000
Common Stock————01,000
Class A Common Stock322210
Class B Common Stock111120
Convertible Founder Stock————00
Additional paid-in capital3,447,9702,953,0802,453,2931,980,3351,599,96299,575
Accumulated other comprehensive income (loss)5,656(2,641)1,270(9,456)(830)228
Accumulated deficit(2,284,491)(1,989,216)(1,644,151)(1,201,405)(748,854)(406,053)
Total stockholders’ equity1,169,139961,226810,415769,477850,281(306,249)
Common Stock—————1,000
Total liabilities and stockholders’ equity2,985,2702,694,9112,460,8092,344,8492,342,729526,119

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.